BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23220088)

  • 1. δ-Catenin overexpression promotes angiogenic potential of CWR22Rv-1 prostate cancer cells via HIF-1α and VEGF.
    He Y; Kim H; Ryu T; Kang Y; Kim JA; Kim BH; Lee JH; Kang K; Lu Q; Kim K
    FEBS Lett; 2013 Jan; 587(2):193-9. PubMed ID: 23220088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatic Hydrocarbon Receptor Suppresses Prostate Cancer Bone Metastasis Cells-Induced Vasculogenesis of Endothelial Progenitor Cells under Hypoxia.
    Huang S; Guo Y; Jacobi A; Li Z; Huang S; He J; Liu X; Tang Y
    Cell Physiol Biochem; 2016; 39(2):709-20. PubMed ID: 27448695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.
    Riddell JR; Maier P; Sass SN; Moser MT; Foster BA; Gollnick SO
    PLoS One; 2012; 7(11):e50394. PubMed ID: 23185615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hypoxia inducible factor-1α downregulates the expression of epithelial to mesenchymal transition early marker proteins without undermining cell survival in hypoxic lens epithelial cells.
    Cammarata PR; Neelam S; Brooks MM
    Mol Vis; 2015; 21():1024-35. PubMed ID: 26392741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 12-Lipoxygenase and the regulation of hypoxia-inducible factor in prostate cancer cells.
    Krishnamoorthy S; Jin R; Cai Y; Maddipati KR; Nie D; Pagès G; Tucker SC; Honn KV
    Exp Cell Res; 2010 Jun; 316(10):1706-15. PubMed ID: 20303950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
    Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
    Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
    Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
    Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. δ-Catenin, a Wnt/β-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and metabolic reprogramming.
    Nopparat J; Zhang J; Lu JP; Chen YH; Zheng D; Neufer PD; Fan JM; Hong H; Boykin C; Lu Q
    Oncogene; 2015 Mar; 34(12):1542-52. PubMed ID: 24727894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of STAT3 and HIF-1 alpha mediates anti-angiogenic activity of betulinic acid in hypoxic PC-3 prostate cancer cells.
    Shin J; Lee HJ; Jung DB; Jung JH; Lee HJ; Lee EO; Lee SG; Shim BS; Choi SH; Ko SG; Ahn KS; Jeong SJ; Kim SH
    PLoS One; 2011; 6(6):e21492. PubMed ID: 21731766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Sonawane V; Rathos MJ; Kumar S; Joshi KS
    BMC Cancer; 2011 Aug; 11():338. PubMed ID: 21819554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
    Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
    Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumor δ-catenin heterogeneity driven by genomic rearrangement dictates growth factor dependent prostate cancer progression.
    Li M; Nopparat J; Aguilar BJ; Chen YH; Zhang J; Du J; Ai X; Luo Y; Jiang Y; Boykin C; Lu Q
    Oncogene; 2020 May; 39(22):4358-4374. PubMed ID: 32313227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
    Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
    Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated action of hypoxia-inducible factor-1α and β-catenin in androgen receptor signaling.
    Mitani T; Harada N; Nakano Y; Inui H; Yamaji R
    J Biol Chem; 2012 Sep; 287(40):33594-606. PubMed ID: 22865883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells.
    Park KY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Kim SH; Lim S; Kim HC; Lü J; Kim SH
    Biol Pharm Bull; 2010; 33(11):1835-40. PubMed ID: 21048308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells.
    Cho SY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Chen CY; Lee EO; Kim SH
    J Pineal Res; 2011 Aug; 51(1):87-93. PubMed ID: 21392092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
    Alqawi O; Moghaddas M; Singh G
    Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.